Research Findings from Hematology-Oncology Department Update Understanding of Breast Cancer (Insights Into the Emerging Entity of HER2-Low Breast Cancer).

Předmět:	BREAST cancer EPIDERMAL growth factor receptors METASTATIC breast cancer
Zdroj:	Women's Health Weekly; 7/12/2024, p958-958, 1p
Abstrakt:	A recent report from the Hematology-Oncology Department highlights the emerging entity of HER2-Low Breast Cancer (BC), which is a subtype of BC with distinct clinical and molecular characteristics. This subtype is characterized by low levels of HER2 protein expression and may have a more favorable prognosis compared to HER2-positive BC. Ongoing research is focused on identifying genetic mutations associated with HER2-Low BC and developing targeted therapies. The review aims to provide a better understanding of this subtype and potentially improve interventions and standards of care. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu